Stockscreener 앱 받기
6.78
1.95%
0.13
시장 영업 전:
6.78
전일 마감가:
$6.65
열려 있는:
$6.61
하루 거래량:
74,274
Relative Volume:
0.28
시가총액:
$338.75M
수익:
$13.55M
순이익/손실:
$-25.32M
주가수익비율:
-12.51
EPS:
-0.542
순현금흐름:
-
1주 성능:
+2.11%
1개월 성능:
+5.94%
6개월 성능:
+21.29%
1년 성능:
+0.00%
1일 변동 폭
$6.50
$6.84
1주일 범위
$6.385
$6.91
52주 변동 폭
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
명칭
Capsovision Inc
전화
(408) 370-4790
주소
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.78 | 332.26M | 13.55M | -25.32M | 0 | -0.542 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
CV Q1 2026 Earnings: EPS Misses Estimates but Stock Gains 1.95%Final Results - thelegaladvocate.com
CapsoVision Inc. (CV) Edges Higher Amid Consolidation – Key Levels to WatchReversal Setup Alerts - thelegaladvocate.com
CV Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEPS Estimate Trend - thelegaladvocate.com
CapsoVision Stock Edges Higher as FDA AI Decision Becomes the Real Test - Bez Kabli
CV Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesGuidance vs Actual - thelegaladvocate.com
CapsoVision (CV) Q1 2026 Earnings: EPS Miss Raises Concerns Amid Operational UncertaintyProfitability Analysis - Newser
CapsoVision Inc. (CV) Gains 1.77% as Shares Test Key Resistance Near $7.23Community Pattern Alerts - Newser
CapsoVision Inc. (CV) Advances 1.18% as Price Moves Toward ResistanceMedian Line - thelegaladvocate.com
CapsoVision (CV) Q1 2026 Miss: What Went WrongConsensus Beat Rate - Newser
CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026 - MSN
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
U.S. Smart Pills Market to Reach USD 619.10 Million by 2033 as - openPR.com
CapsoVision, Inc. (CV) AI-Powered Stock Analysis - Meyka
CapsoVision Reports Stable Q1 Revenue and Expands AI Medical Pipeline - HarianBasis.co
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 - Investing.com UK
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 By Investing.com - Investing.com South Africa
CapsoVision Q1 Earnings Call Highlights - sharewise.com
CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading - ChartMill
CAPSOVISION ($CV) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings call transcript: CapsoVision misses Q1 2026 EPS forecast, stock rises - Investing.com
Transcript: CapsoVision Q1 2026 Earnings Conference Call - Benzinga
CapsoVision Q1 2026 Earnings Call Transcript - MarketBeat
CapsoVision Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CapsoVision, Inc 1Q 2026: Revenue $2.79M, EPS $(0.15) — 10-Q Summary - TradingView
CapsoVision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CapsoVision Reports First Quarter 2026 Financial Results - Yahoo Finance UK
CapsoVision, Inc.Common Stock (Nasdaq:CV) Stock Quote - FinancialContent
User | times-online.comCapsoVision, Inc.Common Stock (Nasdaq:CV) Stock Quote - FinancialContent
CapsoVision Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
TradingKey - TradingKey
Number of shareholders of CapsoVision, Inc. – NASDAQ:CV - TradingView
Number of shareholders of CapsoVision, Inc. – DUS:H6U - TradingView
Earnings Preview: CapsoVision to Report Financial Results Post-market on May 14 - Moomoo
What makes CapsoVision (CV) different from its competitors? (Breakout Watch) 2026-05-07Delta Trends - newser.com
CapsoVision (NASDAQ: CV) amendment reports 5.10M shares owned by Harari group - Stock Titan
CapsoVision (CV) sales head exercises 107,357 options, boosts share stake - Stock Titan
CapsoVision (CV) price target decreased by 16.00% to 10.71 - MSN
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 - GlobeNewswire
CapsoVision (CV) 2026 proxy: director elections, Baker Tilly ratification and pay - Stock Titan
Capsule Endoscope Systems Market Climbs to USD 0.6 Billion - openPR.com
CapsoVision (CV) Stock Outlook | Q4 2025: EPS Tops ViewsUser Trade Ideas - Newser
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - MSN
CapsoVision And 2 Other Growth Stocks With Significant Insider Ownership - Yahoo Finance
CV (CapsoVision) reports far narrower Q4 2025 loss than estimates, shares stay flat in today’s trading.Net Margin - Cổng thông tin điện tử Tỉnh Sơn La
[EFFECT] CapsoVision, Inc SEC Filing - Stock Titan
CapsoVision (NASDAQ: CV) registers 2.87M PIPE shares for resale - Stock Titan
CapsoVision (CV) Stock Initiates Position (Froths) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
CapsoVision (CV) Stock Signal Based Trade (+11.30%) 2026-04-18Stock Distribution - Cổng thông tin điện tử Tỉnh Sơn La
Capsovision Inc (CV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):